Cadence Pharmaceuticals (CADX)

6.94 +0.07  +1.02%  May 21, 2:14PM
Add to Watchlists Create an Alert

Cadence Pharmaceuticals Cash from Financing Quarterly:

0.053M for March 31, 2013
View Full Chart

Cadence Pharmaceuticals Cash from Financing Quarterly Chart

    Cadence Pharmaceuticals Historical Cash from Financing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 0.053M
    Dec. 31, 2012 0.354M
    Sept. 30, 2012 0.001M
    June 30, 2012 0.007M
    March 31, 2012 0.089M
    Dec. 31, 2011 77.88M
    Sept. 30, 2011 -1.558M
    June 30, 2011 0.796M
    March 31, 2011 0.605M
    Dec. 31, 2010 103.67M
    Sept. 30, 2010 0.034M
    June 30, 2010 14.79M
    March 31, 2010 -1.469M
    Dec. 31, 2009 -1.450M
       
    Sept. 30, 2009 -1.726M
    June 30, 2009 -2.213M
    March 31, 2009 84.05M
    Dec. 31, 2008 -2.141M
    Sept. 30, 2008 -2.088M
    June 30, 2008 -0.6976M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro

    About Cash From Financing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
    Learn More

    Get data for

    CADX Cash from Financing Quarterly Benchmarks

    Companies
    Bristol-Myers Squibb -44.00M
    Dendreon 2.611M
    Targacept

    CADX Cash from Financing Quarterly Rankings

    Overall 78th percentile
    1753 of 8002
    Sector 57th percentile
    288 of 684 in Healthcare
    Industry 48th percentile
    127 of 248 in Biotechnology

    CADX Cash from Financing Quarterly Range, Past 5 Years

    Minimum -2.213M Jun 2009
    Maximum 103.67M Dec 2010
    Average 13.45M